Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DUKE UNIVERSITY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2014-09-09 to 2024-11-30
Current total value of award: $1140891.22
Description: A PHASE I, SINGLE DOSE, OPEN-LABEL, PARALLEL GROUP STUDY COMPARING THE PHARMACOKINETICS AND SAFETY OF PA-824 IN SUBJECTS WITH MILD, MODERATE AND SEVERE HEPATIC IMPAIRMENT TO MATCHED, NORMAL, HEALTHY SUBJECTS